Alzheimer’s testing goes painless, homebound with Neurogen-Tasso partnership
The collaboration aims to make Alzheimer’s biomarker testing more accessible and less intimidating
The collaboration aims to make Alzheimer’s biomarker testing more accessible and less intimidating
Roche also shared the design of its upcoming Phase III TRONTIER 1 and 2 trials investigating trontinemab in people with early symptomatic Alzheimer’s disease
Subscribe To Our Newsletter & Stay Updated